Sign in

Clinical Epidemiology Basel

@clinepi-basel.bsky.social
98 followers 28 following 52 posts

Towards better clinical research with an impact on clinical care and global public health

PostsRepliesMedia
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 03/03/2026
Interested in conducting meta-research with on Advancing Equity, Diversity, and Inclusion in Clinical Trials (EDICT)? Applications are open for 16 fully funded PhD positions — including two positions in Basel at the Division of Clinical Epidemiology. Find out more and apply at: www.edictproject.eu
edictproject.eu
EDICT - Advancing Equity, Diversity and Inclusion in Clinical Trials
EDICT is a Marie Skłodowska-Curie Doctoral Network training 16 PhD researchers to transform equity, diversity and inclusion in clinical trials across Europe.
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 03/11/2025
The #ComBaCaL project in Lesotho shows that empowering community health workers to diagnose hypertension and diabetes isn't just feasible — it delivers high population coverage at moderate cost: www.thelancet.com/journals/lan...
thelancet.com
Costs and coverage of community health worker-led hypertension and diabetes screening in rural Lesotho (ComBaCaL): cost–consequence analysis of a cohort study
CHWs, by use of a clinical decision support application run on an electronic tablet, provided high hypertension and diabetes screening coverage at moderate costs. Our findings support the integration ...
010
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/10/2025
We thank Krebsliga beider Basel and @snsf.ch for the support of the study. 🤝
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/10/2025
The study protocol for the process evaluation substudy of the #LIQPLAT trial, which evaluates the use of ctDNA in decision-making for advanced solid cancers, is now published in #BMJOpen. 🔗 Full article: lnkd.in/eFWBhtze ℹ️ More information on the LIQPLAT trial: liqplat.com
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/10/2025
👏 Congratulations to all co-authors 🙏 Many thanks to all participants, SHCS physicians, research personnel, and funders who made this innovation possible! @snsf.ch @FAG Basel
010
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/10/2025
Our mixed-methods study explored the barriers and facilitators of this implementation process. 🧩 Full open-access article @jclinepi.bsky.social : www.sciencedirect.com/science/arti...
sciencedirect.com
Implementing a randomization consent to enable Trials within Cohorts in the Swiss HIV Cohort Study – A mixed-methods study
Trials within Cohorts (TwiCs) is a promising design to make randomized trials more efficient. Cohort participants are asked for consent to be randomiz…
142
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/10/2025
Trials within Cohorts (#TwiCs) is an innovative study design that embeds randomized trials directly within ongoing cohort studies. The Swiss HIV Cohort Study (#SHCS) — a well-established, nationwide cohort — has now implemented the TwiCs design for the first time in Switzerland.
111
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/09/2025
Here the full story: jamanetwork.com/journals/jam... Well presented Johannes👏
jamanetwork.com
Nonregistration, Discontinuation, and Nonpublication of Randomized Trials
This systematic review describes the percentages of randomized clinical trials approved in 2016 that are unregistered, prematurely discontinued, or unpublished.
022
Reposted by Clinical Epidemiology Basel
JAMA Network Open @jamanetworkopen.com · 06/09/2025
Today at #PRC10: Analysis of 347 RCTs in Europe and Canada in 2016 Co-author @schwenkej.bsky.social found industry-sponsored trials were more often completed and available. 🔗 Read the study: ja.ma/41I2etz @peerreviewcongress.bsky.social
061
Reposted by Clinical Epidemiology Basel
Peer Review Congress #PRC11 Coming 2029! @peerreviewcongress.bsky.social · 05/09/2025
Nonregistration, premature discontinuation due to poor recruitment, and nonpublication of #RCT results remain major challenges, especially for nonindustry trials @schwenkej.bsky.social @clinepi-basel.bsky.social @unibas.ch @mcmasteruniversity.bsky.social #OpenScience #MetaResearch #PeerReview
254
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 28/08/2025
📝 New study: Mental health & substance use among adolescents in Lesotho🇱🇸 Older teens (15–17) most affected: girls → more mental health issues, boys → more substance use. Yet only 17% accessed care. Urgent need for youth-friendly services. Read more: onlinelibrary.wiley.com/doi/10.1111/...
020
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/07/2025
ART works — but strong monitoring & infant care are key to ending vertical HIV transmission. Full article: onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/07/2025
The challenge? Only 44% of cases had viral load monitoring in line with guidelines. Infant testing & prevention were also inconsistent.
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/07/2025
In a study of 353 pregnancies among people living with HIV, vertical transmission was just 1% — far below the ~33% expected without treatment.
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 30/07/2025
🤰🤱 New data from Lesotho: Antiretroviral therapy during pregnancy & breastfeeding is preventing infants from HIV. But there’s still more to do. 🧵
120
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 28/07/2025
ComBaCaL also powers Trials within Cohorts, testing community-led interventions to boost treatment & control for NCDs. More here: bmjopen.bmj.com/content/15/7...
bmjopen.bmj.com
Cohort profile: the open, prospective Community-Based chronic Care Lesotho (ComBaCaL) cohort – design, baseline chronic disease risk factors and hypertension and diabetes care cascades
Purpose The open, prospective Community-Based chronic Care Lesotho (ComBaCaL) cohort is the first study to comprehensively investigate socioeconomic indicators, common chronic diseases and their risk ...
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 28/07/2025
Findings show heavy burdens: Hypertension: 17% Diabetes: 4% HIV: 15%
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 28/07/2025
🚨New publication! 📝 Community-Based chronic Care Lesotho (ComBaCaL) cohort profile a cohort of 14,700+ people in rural Lesotho, uncovering the intersection of chronic disease, poverty, & care access.
111
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 08/07/2025
💇🏾‍♀️ New publication from our team: Hair Salons as a promising space to provide HIV & Sexual and SRH services for young women in Lesotho 💭 The team is currently looking for funding to implement a pilot - ideas welcome! Read more here: bmcpublichealth.biomedcentral.com/articles/10....
bmcpublichealth.biomedcentral.com
Hair salons as a promising space to provide HIV and sexual and reproductive health services for young women in Lesotho: a citizen scientist mixed-methods study - BMC Public Health
Introduction Adolescent girls and young women in southern Africa are disproportionately affected by HIV and sexual and reproductive health (SRH) challenges. There is a need for more accessible and de-...
053
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 03/07/2025
🥁Now publication on the availability of trial protocols! 🔗Check out the link for the open access paper: www.sciencedirect.com/science/arti... @jclinepi.bsky.social @unibas.ch @dkf.unibas.ch @snsf.ch
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 23/06/2025
Grace Yoon, Natalie Johnson, Moleboheng Mokebe, Palesa Mahlatsi, Malebanye Lerotholi, Niklaus Labhardt, Nadine Tschumi, Alastair van Heerden, Jennifer M. Belus, Irene Falgas-Bague
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 23/06/2025
www.cambridge.org/core/journal...
cambridge.org
Face-to-face, confidential and health worker-led: Understanding the preferences for behavioral health services among people with HIV in Lesotho | Cambridge Prisms: Global Mental Health | Cambridge Cor...
Face-to-face, confidential and health worker-led: Understanding the preferences for behavioral health services among people with HIV in Lesotho - Volume 12
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 23/06/2025
💡 New study on behavioral health for people with HIV in Lesotho 🇱🇸: Phone-based care has pros & cons, but trusted individuals are key for support & accountability. From Butha-Buthe and Mokhotlong. 🧑‍⚕️📞👥 Read more 👉
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 20/06/2025
🌞 ClinEpi Summer Event 2025 We just wrapped up an unforgettable summer event featuring fun quizzes & games and ending off with an exciting cooking challenge 🍴 A huge thank you to everyone who joined, competed and organised this event, we are already looking forward to the next one!
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 06/06/2025
Grateful to all collaborators@snsf.ch @unibas.ch @dkf.unibas.ch @ox.ac.uk and to all participating journals from the @bmj.com! 🤝
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 06/06/2025
Our secondary analysis of 533 peer reviewer reports found that reminders about reporting guidelines increased reviewer attention—but the effect diminished due to article rejections and limited implementation by authors. 🔗Full publication@jclinepi.bsky.social : www.sciencedirect.com/science/arti...
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 20/05/2025
New publication from our team: Drivers of chronic depressive and harmful alcohol use symptoms among adults living with HIV in Lesotho: pathways for integrated interventions 🔗: www.sciencedirect.com/science/arti...
sciencedirect.com
Drivers of chronic depressive and harmful alcohol use symptoms among adults living with HIV in Lesotho: pathways for integrated interventions
Mental health problems are prevalent among people with HIV (PWH) in Southern Africa. However, mental health problems are substantially under-diagnosed…
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 19/05/2025
🚀 Join us for Geneva Digital Health Day 2025! 🌍💻 Felix Gerber will give a short presentation on digital innovation in low- and middle-income countries. 📅 Date: Thursday, 22 May 2025 🕘 Time: 09:00–17:30 CET 📍 Location: Campus Biotech, Geneva, Switzerland 🔗 Register here: gdhub.org/25gdhd/
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 16/05/2025
🚀 New study out Clinical trials often face overoptimistic budgets and funding shortfalls, leading to costly trial discontinuations. We reviewed Swiss budgeting tools and found untested, inconsistent methods without prespecified cost ranges. Article: trialsjournal.biomedcentral.com/articles/10....
trialsjournal.biomedcentral.com
Clinical trial budgeting approaches in Switzerland—a meta-research study - Trials
Background Conducting clinical trials is resource demanding. Mirroring challenges experienced elsewhere, clinical trials conducted in Switzerland often face overoptimistic budget estimations and insuf...
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 15/05/2025
Congratulations to @alainamstutz.bsky.social et al. to this work!
020
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 15/05/2025
With over 96% of global trial data on this topic included, this #IPDMA, published in @lancetrespirmed.bsky.social and initiated by #EU-RESPONSE, provides the most comprehensive analysis for JAK inhibitors for adults hospitalized due to #COVID19. Full article: www.thelancet.com/journals/lan...
thelancet.com
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials
This IPDMA of RCTs in adults admitted to hospital due to COVID-19 found that JAK inhibitors reduced mortality across all levels of respiratory support, independent of dexamethasone or tocilizumab, and...
144
Reposted by Clinical Epidemiology Basel
The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 14/05/2025
📰 New Article: Effects of Janus kinase inhibitors in adults admitted to hospital with #COVID19: a systematic review and IPD meta-analysis of randomised clinical trials Findings suggested that JAK inhibitors reduced mortality across all levels of respiratory support 🔗 tinyurl.com/2hprv99v
Research in context panel:

"Our IPDMA presents the most comprehensive summary of all existing randomised evidence (including >96% of participants recruited globally on the topic) and subgroup analyses settling the issue of discordant guidelines. JAK inhibitors seem a safe and efficacious treatment option for adults hospitalised with COVID-19 when given in addition to usual care."
157
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 15/04/2025
New research was presented from longstanding collaborations, including work by #SolidarMed and the Division of Clinical Epidemiology. The full list of abstracts is available here: 👉 heyzine.com/flip-book/d0...
lnkd.in
LinkedIn
This link will take you to a page that’s not on LinkedIn
001
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 15/04/2025
Last week in Maseru, leaders from Lesotho’s Ministry of Health and local organisations gathered for the 13th National Health Research Symposium. 🇱🇸📊 The event highlighted the importance of locally led, evidence-based research — now more critical than ever! 🩺📚
111
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 31/03/2025
We had the pleasure of hosting Prof. @stephensenn.bsky.social in Basel for a public lecture on statistical principles in #RCTs. Thanks to #PPHS for making it possible — and to Prof. Senn for the inspiring talk and visit! @unibas.ch @dkf.unibas.ch
021
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/03/2025
🌍 EVENT: Challenges & Opportunities in Global Mental Health 🧠 Join us at the @swisstph.ch on June 3, 2025 (2:00 PM – 5:00 PM) for a discussion with experts from @columbiauniversity.bsky.social , @uzh-ch.bsky.social, @swisstph.ch , and University Hospital Basel! 🔗 RSVP: nat.johnson@unibas.ch
031
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 03/03/2025
📅 So please join us on March 26th, 16:15–17:45 in the nicest seminar room at the University of Basel, Seminarraum 201 der alten Universität, Rheinsprung 9.
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 03/03/2025
🚨Save the date! March 26th, Prof. @stephensenn.bsky.social will travel to #Basel and give a presentation on methodology and statistics in #RCTs. He will share his insights on why we randomize trials, the value of balance, whether trials should be representative, and much more.
Seminarraum 201, Alte Universität Basel, Rheinsprung 201, Basel
142
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 28/02/2025
📢 New publication: Prevalence and factors associated with dementia in Lesotho We found a probable dementia prevalence of 5% in Lesotho, aligning with regional estimates for Africa. 🧠 alz-journals.onlinelibrary.wiley.com/doi/10.1002/...
alz-journals.onlinelibrary.wiley.com
Prevalence and factors associated with dementia in Lesotho: A cross‐sectional, population‐based study
You have to enable JavaScript in your browser's settings in order to use the eReader.
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/02/2025
— J Brown, L Motaboli, M Lerotholi, M Kohler, K Hänggi, M Mokete, M Chakela, M Kao, M Kopo, M Mokebe, L Urda, B Nsakala, B Lukau, I Ayakaka, A Amstutz, J Ehmer, A Klicpera, T Klimkait, T Glass, J Muhairwe, F Chammartin, N Tschumi, N Labhardt
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/02/2025
Looking ahead, we plan to expand drug resistance testing and focus on comorbidities and aging in people living with HIV. (4/4)
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/02/2025
We've gathered data on full coverage of HIV viral load testing across two districts in Lesotho, shedding light on gaps in the care cascade and the rollout of dolutegravir. (3/4)
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/02/2025
Prospective cohorts, like the Viral Load Cohort North-East Lesotho (VICONEL), are crucial for monitoring service delivery and health outcomes in HIV programs. Our goal: Generate evidence to improve HIV care in Lesotho & beyond. (2/4)
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 14/02/2025
🧪 Insights from the VICONEL Cohort on HIV Care in Lesotho 🧵(1/54) Check out the full cohort profile here: bmjopen.bmj.com/content/15/2...
bmjopen.bmj.com
Cohort profile: the Viral load Cohort North-East Lesotho (VICONEL) from 2016 to 2023 – cohort description, test volumes, predictors of viraemia and the road ahead
Purpose The prospective Viral load Cohort North-East Lesotho (VICONEL) aims to support clinical management and generate scientific evidence to inform HIV care. Specifically, VICONEL allows for the mon...
112
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 11/02/2025
Read the full article here: www.sciencedirect.com/science/arti... (4/4) — Jennifer Belus, Kristen Regenauer, Thanh Lu, Sean Murphy, Alexandra Rose, Yvonne Ochieng, John Joska, Hlombekazi Sybil Majokweni, Lena Skovgaard Andersen, Bronwyn Meyers, Steven Safren, Jessica Magidson
000
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 11/02/2025
These findings suggest that addressing behavioral health could lead to broader improvements, like higher employment, in populations facing substance use and HIV challenges. (3/4)
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 11/02/2025
The employment rate in the intervention group increased from 13% to 59% over 6 months! Meanwhile, the group receiving only substance use treatment referrals showed a smaller increase (29% to 38%). (2/4)
100
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 11/02/2025
📊 New study on the effectiveness of behavioral interventions for substance use & HIV. Our pilot study, 'Khanya', shows how brief, skills-based interventions can also improve employment rates! 🧵 (1/4)
110
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 10/02/2025
🦠 New publication from COVERALL (Corona Vaccine Platform Trial): Low agreement & frequent invalid controls in 2 SARS-CoV-2 T-cell assays in people with compromised immune function. This work honours Annette Audigé for her passion & dedication to research!👏🕊️ journals.plos.org/plosone/arti...
011
Clinical Epidemiology Basel @clinepi-basel.bsky.social · 04/02/2025
Read the full article here: journals.sagepub.com/doi/10.1177/... (4/4) — Jennifer M. Belus, Alastair van Heerden, Abigail Hines, Thembelihle Pita, YVONNE MDAKANE, Jessica Magidson, Heidi van Rooyen, Ruanne Barnabas
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
010